U.S. orphan drug report 2018

Growth Trends in Rare Disease Treatments

This report depicts the developments of orphan drug industry and market in the United States. Among other issues, it focuses on patent exclusivity, pricing, and patient populations. This is the first part of IQVIA's 2018 report on orphan drugs in the United States.
  • Language: English
  • Released: October 2018
Study included in Corporate Account only.
More than 7,500
companies
trust
Statista
Recommended studies and dossiers
Show more
Recent studies and dossiers
You may also be interested in...
Statista is a great source of knowledge, and pretty helpful to manage the daily work.

Christof Baron about Statista CEO, MindShare Germany

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!